Post-approval studies (Phase 4)Study completedNCT02703194
What this trial is testing
Leflunomide for Maintenance of Remission in IgG4 Related Disease
Who this might be right for
Immunoglobulin G4 Related Sclerosing Disease
Chinese PLA General Hospital 68